Sorafenib-induced erythema multiforme for metastatic renal cell carcinoma.

Subjects

Subjects :

Adult
Aged
Aged, 80 and over
Carcinoma, Renal Cell drug therapy
Carcinoma, Renal Cell pathology
Erythema Multiforme diagnosis
Erythema Multiforme drug therapy
Female
Humans
Kidney Neoplasms drug therapy
Kidney Neoplasms pathology
Kidney Neoplasms secondary
Male
Niacinamide analogs & derivatives
Phenylurea Compounds
Sorafenib
Treatment Outcome
Antineoplastic Agents adverse effects
Benzenesulfonates adverse effects
Carcinoma, Renal Cell complications
Erythema Multiforme chemically induced
Kidney Neoplasms complications
Pyridines adverse effects

Details

Language :

English

ISSN :

1569-8041

Volume :

21

Issue :

7

Database :

MEDLINE

Journal :

Annals of oncology : official journal of the European Society for Medical Oncology

Publication Type :

Report

Accession number :

20573851

Full Text :

https://doi.org/10.1093/annonc/mdq299